|
Company:
|
ONCORUS, INC. (ONCR)
|
|
Form Type:
|
8-K
|
|
Filing Date:
|
6/23/2022
|
|
CIK:
|
0001671818
|
|
Address:
|
50 HAMPSHIRE STREET
SUITE 401
|
|
City, State, Zip:
|
CAMBRIDGE, Massachusetts 02139
|
|
Telephone:
|
857-320-6400
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$1.38
|
Change:
0.07 (5.34%)
|
Trade Time:
Aug 10
|
Market Cap:
$35.72M
|
|
|
|
|
|
|
Description of Business
|
|
We are a clinical-stage biopharmaceutical company focused on developing
next-generation, systemically active viral immunotherapies to transform outcomes
for cancer patients. Using our two proprietary platforms, we are developing a
pipeline of intratumorally and intravenously administered product candidates
designed to selectively attack and kill tumor cells and deliver transgenes to
stimulate multiple arms of the immune system against tumors. We believe the
therapies that we are developing will bring significant benefit to many patients
who are currently underserved by approved immuno-oncology therapies, including
other viral immunotherapies and immune checkpoint inhibitors.
|
|
|
|